| Sheila Mccabe Bisanzo, LICSW | |
|
182 Yacht Haven Dr, Shelburne, VT 05482-7774 | |
| (508) 380-9085 | |
| Not Available |
| Full Name | Sheila Mccabe Bisanzo |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 182 Yacht Haven Dr, Shelburne, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023591641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 114861-1 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Mccabe Bisanzo, LICSW 182 Yacht Haven Dr, Shelburne, VT 05482-7774 Ph: () - | Sheila Mccabe Bisanzo, LICSW 182 Yacht Haven Dr, Shelburne, VT 05482-7774 Ph: (508) 380-9085 |
News Archive
Highly publicized events such as school shootings arouse public interest in the effects of media violence exposure on children, yet there is still considerable public debate about whether to take this issue seriously.
TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.
Humans began to develop systems of reading and writing only within the past few thousand years. Our reading abilities set us apart from other animal species, but a few thousand years is much too short a timeframe for our brains to have evolved new areas specifically devoted to reading.
Shih-Hsin (Eddy) Yang, M.D., Ph.D., the ROAR Southeast Cancer Foundation Endowed Chair in the University of Alabama at Birmingham Department of Radiation Oncology, has received a $450,000 grant from Susan G. Komen for the Cure to further investigate HER2-positive breast tumor susceptibility to PARP inhibitors.
A new study found that fluoxetine (Prozac-) and citalopram (Celexa-) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D. from the Brighton and Sussex Medical School (BSMS) in the UK studied the anti-arthritic potential of these drugs, known as selective serotonin reuptake inhibitors (SSRIs), most commonly used to treat depression.
› Verified 8 days ago
Debra Niemasz, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 50 Cottage Ln, Shelburne, VT 05482 Phone: 802-238-9278 | |
Laurie Bomba, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5138 Shelburne Rd, Shelburne, VT 05482 Phone: 802-865-3450 Fax: 802-347-6112 | |
Ms. Jessica A Young, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 145 Pine Haven Shores Rd, Ste 2173, Shelburne, VT 05482 Phone: 802-557-0128 | |
Ms. Gail Engels, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5138 Shelburne Rd, Box 367, Shelburne, VT 05482 Phone: 802-864-4513 Fax: 802-985-5061 | |
Katherine Porcelli, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5138 Shelburne Rd Ste 12, Shelburne, VT 05482 Phone: 802-865-3450 | |
Ms. Jennifer Katherine Daley, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10 Marsett Rd, Suite 3, Shelburne, VT 05482 Phone: 802-448-2138 Fax: 802-985-0748 |